DGAP-News: Epigenomics AG / Key word(s): Half Year Results/Quarter Results 07.08.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019 Berlin (Germany) and San Diego, CA (U.S.A.), August 7, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY, […]
Author: mark
07. August 2019
Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019
Read more
24. July 2019
Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates
DGAP-News: Epigenomics AG / Key word(s): Study results/Study 24.07.2019 / 21:42 The issuer is solely responsible for the content of this announcement. Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates Berlin, 24 July 2019 […]
11. July 2019
Epigenomics AG Receives MedTech Outlook’s 2019 Top 10 In-Vitro Diagnostics Award
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 11.07.2019 / 14:30 The issuer is solely responsible for the content of this announcement. Epigenomics AG Receives MedTech Outlook’s 2019 Top 10 In-Vitro Diagnostics Award Company recognized for its leadership in advancing blood-based tests to diagnose cancer Berlin (Germany) and San Diego, CA (U.S.A.), July 11, 2019 – […]
17. June 2019
Epigenomics AG: New Clinical Data Support the Utility of Epi proColon(R) Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
DGAP-News: Epigenomics AG / Key word(s): Study results/Scientific publication 17.06.2019 / 14:00 The issuer is solely responsible for the content of this announcement. New Clinical Data Support the Utility of Epi proColon Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome Minimally-invasive blood test […]
04. June 2019
Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June
DGAP-News: Epigenomics AG / Key word(s): Conference 04.06.2019 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics AG to Participate in Raymond James Life Sciences and MedTech Conference in June Berlin (Germany) and San Diego, CA (U.S.A.), June 4, 2019 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”) today […]
03. June 2019
DGAP-DD: Epigenomics AG deutsch
Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen 03.06.2019 / 10:22 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. 1. Angaben zu den Personen, die Führungsaufgaben wahrnehmen, sowie zu den in enger Beziehung zu ihnen stehenden Personen a) Name Name und […]